Differential recruitment of UBQLN2 to nuclear inclusions in the polyglutamine diseases HD and SCA3

Differential recruitment of UBQLN2 to nuclear inclusions in the polyglutamine diseases HD and SCA3

Accumulation of mutant polyglutamine proteins in intraneuronal inclusions is a hallmark of polyglutamine diseases. Impairment of protein clearance systems and sequestration of clearance-related proteins into inclusions occur in many protein folding diseases, including polyglutamine diseases. The ubi...

Full description

Bibliographic Details
Main Authors:	Li Zeng, Bo Wang, Sean A. Merillat, Eiko N. Minakawa, Matthew D. Perkins, Biswarathan Ramani, Sara J. Tallaksen-Greene, Maria do Carmo Costa, Roger L. Albin, Henry L. Paulson
Format:	Article
Language:	English
Published:	Elsevier 2015-10-01
Series:	Neurobiology of Disease
Subjects:	UBQLN2 SCA3 Huntington's disease Polyglutamine UBA UBL
Online Access:	http://www.sciencedirect.com/science/article/pii/S0969996115300012

Similar Items

Overexpression of UBQLN1 reduces neuropathology in the P497S UBQLN2 mouse model of ALS/FTD
by: Shaoteng Wang, et al.
Published: (2020-10-01)

STUDIES OF FACTORS AFFECTING INTRACELLULAR TOXICITY OF THE SCA7 DISEASE PROTEIN ATAXIN - 7 : FOCUS ON ATAXIN-7 DEGRADATION AND OXIDATIVE STRESS
by: Yu, Xin
Published: (2011)

Prognostic and predicted significance of Ubqln2 in patients with hepatocellular carcinoma
by: Yuan‐Deng Luo, et al.
Published: (2020-06-01)

Ubiquilin Networking in Cancers
by: Salinee Jantrapirom, et al.
Published: (2020-06-01)

Gene Deregulation and Underlying Mechanisms in Spinocerebellar Ataxias With Polyglutamine Expansion
by: Anna Niewiadomska-Cimicka, et al.
Published: (2020-06-01)

A Drosophila ortholog of the human MRJ modulates polyglutamine toxicity and aggregation
by: Zahra Fayazi, et al.
Published: (2006-11-01)

Polyglutamine repeats of spinocerebellar ataxia 6 impair the cell-death-preventing effect of CaV2.1 Ca2+ channel—loss-of-function cellular model of SCA6
by: Zenjiro Matsuyama, et al.
Published: (2004-11-01)

THE ROLE OF P53 IN OXIDATIVE STRESS AND POLYGLUTAMINE NEUROTOXICITY
by: Dunn, Jay C.
Published: (2003)

Impaired 26S Proteasome Assembly Precedes Neuronal Loss in Mutant UBQLN2 Rats
by: Wenjuan Zhang, et al.
Published: (2021-04-01)

microRNA dysregulation in polyglutamine toxicity of TATA-box binding protein is mediated through STAT1 in mouse neuronal cells
by: Reema Roshan, et al.
Published: (2017-08-01)

SUMOylation by SUMO2 is implicated in the degradation of misfolded ataxin-7 via RNF4 in SCA7 models
by: Martina Marinello, et al.
Published: (2019-01-01)

Quantitative connection between polyglutamine aggregation kinetics and neurodegenerative process in patients with Huntington’s disease
by: Sugaya Keizo, et al.
Published: (2012-05-01)

Polyglutamine-expanded ataxin-3 causes cerebellar dysfunction of SCA3 transgenic mice by inducing transcriptional dysregulation
by: An-Hsun Chou, et al.
Published: (2008-07-01)

Expression of expanded polyglutamine targets profilin for degradation and alters actin dynamics
by: Barrington G. Burnett, et al.
Published: (2008-06-01)

Pathogenesis of SCA3 and implications for other polyglutamine diseases
by: Hayley S. McLoughlin, et al.
Published: (2020-02-01)

UBQLN2 Promotes the Production of Type I Interferon via the TBK1-IRF3 Pathway
by: Tianhong Chen, et al.
Published: (2020-05-01)

Natural Genetic Variation in Yeast Reveals That NEDD4 Is a Conserved Modifier of Mutant Polyglutamine Aggregation
by: Theodore W. Peters, et al.
Published: (2018-11-01)

Proteasome degrades soluble expanded polyglutamine completely and efficiently
by: Andrej Michalik, et al.
Published: (2004-06-01)

A novel ALS-associated variant in UBQLN4 regulates motor axon morphogenesis
by: Brittany M Edens, et al.
Published: (2017-05-01)

Mutant Huntingtin Forms in Vivo Complexes with Distinct Context-Dependent Conformations of the Polyglutamine Segment
by: Francesca Persichetti, et al.
Published: (1999-10-01)

Toxic intermediates and protein quality control in the polyglutamine disease, SCA3
by: Williams, Aislinn Joanmarie
Published: (2010)

Experimental and Computational Analysis of Polyglutamine-Mediated Cytotoxicity
by: Tang, Matthew
Published: (2012)

Experimental and Computational Analysis of Polyglutamine-Mediated Cytotoxicity
by: Tang, Matthew
Published: (2012)

Experimental and Computational Analysis of Polyglutamine-Mediated Cytotoxicity
by: Tang, Matthew
Published: (2012)

Experimental and Computational Analysis of Polyglutamine-Mediated Cytotoxicity
by: Tang, Matthew
Published: (2012)

Genetic alterations of C9orf72, SOD1, TARDBP, FUS, and UBQLN2 genes in patients with Amyotrophic Lateral Sclerosis
by: Ciftci Vildan, et al.
Published: (2019-01-01)

Mutant UBQLN2P497H in motor neurons leads to ALS-like phenotypes and defective autophagy in rats
by: Tianhong Chen, et al.
Published: (2018-11-01)

<i>Toxoplasma gondii</i> UBL-UBA Shuttle Protein DSK2s Are Important for Parasite Intracellular Replication
by: Heng Zhang, et al.
Published: (2021-07-01)

Evaluation of Antisense Oligonucleotides Targeting ATXN3 in SCA3 Mouse Models
by: Lauren R. Moore, et al.
Published: (2017-06-01)

Expanded ataxin-7 cause toxicity by inducing ROS production from NADPH oxidase complexes in a stable inducible Spinocerebellar ataxia type 7 (SCA7) model
by: Ajayi Abiodun, et al.
Published: (2012-07-01)

miR-337-5p promotes the development of cardiac hypertrophy by targeting Ubiquilin-1 (UBQLN1)
by: Ying Ding, et al.
Published: (2021-01-01)

Transcriptional Dysregulation and Post-translational Modifications in Polyglutamine Diseases: From Pathogenesis to Potential Therapeutic Strategies
by: Chunchen Xiang, et al.
Published: (2018-05-01)

Protein Aggregation Inhibitors as Disease-Modifying Therapies for Polyglutamine Diseases
by: Eiko N. Minakawa, et al.
Published: (2021-02-01)

Prevalence of Trinucleotide Expansions in SCA17/TBP and JPH3 Genes and Octapeptide Insertion in PRNP Gene in Iranian Patients with Huntington-Disease like Syndrome
by: mana zakeri, et al.
Published: (2020-09-01)

UBQLN4 promotes progression of HCC via activating wnt-β-catenin pathway and is regulated by miR-370
by: Yan Yu, et al.
Published: (2020-01-01)

Polyglutamine length-dependent toxicity from α1ACT in Drosophila models of spinocerebellar ataxia type 6
by: Wei-Ling Tsou, et al.
Published: (2016-12-01)

Toward understanding the role of protein context in the polyglutamine disease, SCA3
by: Harris, Ginny Marie
Published: (2011)

Oxidative stress is increased in C. elegans models of Huntington’s disease but does not contribute to polyglutamine toxicity phenotypes
by: Emily Machiela, et al.
Published: (2016-12-01)

A series of N-terminal epitope tagged <it>Hdh</it> knock-in alleles expressing normal and mutant huntingtin: their application to understanding the effect of increasing the length of normal huntingtin’s polyglutamine stretch on CAG140 mouse model pathogenesis
by: Zheng Shuqiu, et al.
Published: (2012-08-01)

Protein Misfolding and Aggregation as a Therapeutic Target for Polyglutamine Diseases
by: Toshihide Takeuchi, et al.
Published: (2017-10-01)